The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.
Identifieur interne : 001203 ( Main/Corpus ); précédent : 001202; suivant : 001204The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.
Auteurs : William H. FrishmanSource :
- Cardiology in review [ 1538-4683 ]
English descriptors
- KwdEn :
- MESH :
- chemical : Chloroquine, Hydroxychloroquine.
- drug therapy : Coronavirus Infections.
- Betacoronavirus, COVID-19, Coronavirus, Humans, Pandemics, Pneumonia, Viral, SARS-CoV-2.
DOI: 10.1097/CRD.0000000000000328
PubMed: 32639241
Links to Exploration step
pubmed:32639241Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.</title><author><name sortKey="Frishman, William H" sort="Frishman, William H" uniqKey="Frishman W" first="William H" last="Frishman">William H. Frishman</name><affiliation><nlm:affiliation>Department of Medicine, New York Medical College/Westchester Medical Center, Valhalla, NY.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020 Sep/Oct</date><idno type="RBID">pubmed:32639241</idno><idno type="pmid">32639241</idno><idno type="doi">10.1097/CRD.0000000000000328</idno><idno type="wicri:Area/Main/Corpus">001203</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001203</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.</title><author><name sortKey="Frishman, William H" sort="Frishman, William H" uniqKey="Frishman W" first="William H" last="Frishman">William H. Frishman</name><affiliation><nlm:affiliation>Department of Medicine, New York Medical College/Westchester Medical Center, Valhalla, NY.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Cardiology in review</title><idno type="eISSN">1538-4683</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (MeSH)</term><term>COVID-19 (MeSH)</term><term>Chloroquine (MeSH)</term><term>Coronavirus (MeSH)</term><term>Coronavirus Infections (drug therapy)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (MeSH)</term><term>SARS-CoV-2 (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Chloroquine</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>COVID-19</term><term>Coronavirus</term><term>Humans</term><term>Pandemics</term><term>Pneumonia, Viral</term><term>SARS-CoV-2</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32639241</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-4683</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>5</Issue><PubDate><MedlineDate>2020 Sep/Oct</MedlineDate></PubDate></JournalIssue><Title>Cardiology in review</Title><ISOAbbreviation>Cardiol Rev</ISOAbbreviation></Journal><ArticleTitle>The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.</ArticleTitle><Pagination><MedlinePgn>217-218</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CRD.0000000000000328</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frishman</LastName><ForeName>William H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Medicine, New York Medical College/Westchester Medical Center, Valhalla, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cardiol Rev</MedlineTA><NlmUniqueID>9304686</NlmUniqueID><ISSNLinking>1061-5377</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>886U3H6UFF</RegistryNumber><NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Cardiol Rev. 2020 Sep/Oct;28(5):266-271</RefSource><PMID Version="1">32769401</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017934" MajorTopicYN="Y">Coronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32639241</ArticleId><ArticleId IdType="doi">10.1097/CRD.0000000000000328</ArticleId><ArticleId IdType="pii">00045415-202009000-00001</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Corum J, Zimmer C. Tracking progress toward a vaccine. New York Times. June 16, 2020;D8.</Citation></Reference><Reference><Citation>Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;105949.</Citation></Reference><Reference><Citation>Schluenz LA, Ramos-Otero GP, Nawarskas JJ. Chloroquine or hydroxychloroquine for management of COVID-19: friend or foe? Card Rev. 2020;28:266–271.</Citation></Reference><Reference><Citation>Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382:1787–1799.</Citation></Reference><Reference><Citation>Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382:2327–2336.</Citation></Reference><Reference><Citation>Rumery K, Yunus F, Frishman WH. Myocardial depression in sepsis: beneficial adaptation or sequelae that requires treatment? Card Rev. 2020;28:256–261.</Citation></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001203 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001203 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32639241
|texte= The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32639241" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |